Boston
,
US
10 - 14 November 2023
American Association for the Study of Liver Diseases (AASLD 2023)
Presentation schedule and materials
Saturday, 11 November 2023
08:00
EST
41248
Publication
Health Care Resource Utilization and Cost Burden of High Disease Severity in US Adults With Nonalcoholic Steatohepatitis: A Retrospective Cohort Study
Michael Charlton1; Ivy Tonnu-Mihara2; Chia-Chen Teng2; Ziqi Zhou2; Feven Asefaha3; Rakesh Luthra4; Amy Articolo5; Anthony Hoovler5; Chioma Uzoigwe6
08:00
EST
2492-C
Publication
Understanding barriers in metabolic dysfunction-associated steatotic liver disease management: Insights from a multi-disciplinary survey of physicians in Europe | BARRIERS – MASLD
Laurent Castera1; William Alazawi2; Elisabetta Bugianesi3; Cyrielle Caussy4; Massimo Federici5; Manuel Romero-Gomez6; Jörn M. Schattenberg7; Ron Basuroy8; Preethy Prasad8; Dmitry Estulin9; Jeffrey V. Lazarus10
MATERIALS AVAILABLE
08:00
EST
2131-A
Publication
A cross-sectional online survey to understand existing NAFLD/NASH curriculum gaps in US primary care provider and specialty training programs
Alina M. Allen1; Michael Charlton2; Anthony Hoovler3; Amy Articolo3; Travis Fisher3; Douglas Dieterich4; Stephen Harrison5; Mazen Noureddin6
Sunday, 12 November 2023
08:00
EST
3306-A
Publication
Belcesiran was well-tolerated and reversibly reduced serum AAT levels in healthy volunteers in a phase 1 study: final results
Michael Soliman1; Dhruv Patel1; Anne-Sophie Sejling1,2; Mohamed Tawfik2; Miao Yu1; Folke Sjoberg3
Monday, 13 November 2023
11:30
EST
46281
Publication
Digital image quantification of the antifibrotic effect of semaglutide and the impact of liver fat in non-alcoholic steatohepatitis
Vlad Ratziu1; Ahsan Shoeb Patel2; Niels Krarup2; Sharat Varma2; Mazen Noureddin3; Arun Sanyal4
Keywords